Register for OBR daily




To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

SNSS $0.65 0.1439 +28.44%
CYTK $11.12 1.1700 +11.76%
SPHS $5.86 0.4600 +8.52%
BDSI $2.55 0.2000 +8.51%
NKTR $17.29 1.1900 +7.39%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

PVCT $0.29 -0.0200 -6.45%
TGTX $5.91 -0.4000 -6.34%
VSTM $1.40 -0.0800 -5.41%
GALE $0.44 -0.0254 -5.40%
NLNK $10.58 -0.5300 -4.77%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | Next > | Last >>

Boston’s Zafgen Cuts Jobs, Shifts Focus On Obesity Drugs After Deaths In Clinical Trials

(Boston Globe) July 20, 2016 - Zafgen Inc. suspended development of an obesity drug whose testing was put on hold last year after two patients died during a clinical trial.
read article (free registration required) 



Valeant Gets FDA OK for Anticonstipation Tablets Developed by Progenics

(NASDAQ/Dow Jones Business News) July 19, 2016 - Valeant Pharmaceuticals International Inc. has received U.S. Food and Drug Administration approval for Relistor tablets to treat opioid-induced constipation for patients with noncancer pain.
read article 



Valeant Drug Should Be Approved With Risk Plan, FDA Advisers Say

(Bloomberg) July 19, 2016 - Valeant Pharmaceuticals International Inc. won the backing of a panel of U.S. regulatory advisers who supported approval of its experimental psoriasis treatment, on the condition that the company takes extra steps to help mitigate possible suicide risk associated with the drug.
read article 



America’s Health Care Prices Are Out Of Control. These 11 Charts Prove It.

(VOX) July 19, 2016 - Humira is an injectable medication that treats arthritis — and one of the best-selling drugs in American history. In 2014 alone, millions of Americans spent a combined $6.5 billion on Humira prescriptions.
read article 



These Drugs Could Cut American Health Costs By $250 Billion (If Only We Could Take Them)

(MarketWatch) July 20, 2016 - Biosimilars are often compared with generics, which have upended drug pricing over the last three decades.
read article 



Cancer Research UK Boosts Efforts To Overcome Deadliest Cancer As Rates Climb

(Cancer Research UK) July 20, 2016 - Cancer Research UK has tripled its investment in pancreatic cancer, one of the hardest cancers to treat, since launching its research strategy in 2014 according to new figures published today (Wednesday).
read press release 



DNA Pioneer James Watson: The Cancer Moonshot Is ‘Crap’ But There Is Still Hope

(STAT/Heavyweights) July 20, 2016 - At a celebration of his friend Arthur Pardee’s 95th birthday last weekend at the American Academy of Arts and Sciences in Cambridge, Mass., James Watson showed no signs of cognitive slowdown, much less of forgetting the world-changing events of 63 years ago.
read article 



Breast Cancer Genetics Study Receives National Cancer Institute Grant

(USC News) July 19, 2016 - A large study headed by researchers from the Keck School of Medicine of USC and two other institutions received $12 million in funding to examine why African-American women die at a higher rate from breast cancer and have more aggressive breast tumors than white women.
read article 



Innovative Technology Improves Detection of Bladder Cancer

(MedStar Washington Hospital Center) July 19, 2016 – Blue Light Cystoscopy with Cysview® detects bladder tumors more easily than standard technique.
read press release 



Invitae Introduces New Breast Cancer STAT Panel For Patients With Breast Cancer Who Need Rapid Test Results To Guide Surgical And Treatment Decisions

(Yahoo! Finance) July 20, 2016 - Test offers results within 8-12 days on seven genes that may influence surgical options.
read article 



Treato Finds Patients Expect Discounts on High Cost Drugs

(TheStreet) July 19, 2016 - Healthcare insights company examines patients' attitudes towards costs related to Xtandi, Ibrance and Xarelto.
read article 



Oncorus Bags $57M, Touts Next-Gen Take on Cancer-Fighting Viruses

(Xconomy Boston) July 19, 2016 - Oncorus’s plan is to develop what it calls a next-generation platform of oncolytic viruses—viruses engineered to get into tumor cells, replicate, and cause them to explode, in the process activating the immune system to destroy any remaining cancer.
read article 



How to Decide if Watchful Waiting Is the Right Choice

(Thomas Jefferson University) July 19, 2016 - A new tool helps remove the emotion around choosing the right approach for prostate cancer.
read press release 



Sanford Physician Assists In Developing New Treatment To Prevent Nausea, Vomiting Caused By Chemotherapy

(Sanford Health) July 19, 2016 - A drug that blocks neurotransmitters could reduce nausea and vomiting caused by chemotherapy, research co-authored by a Sanford Health physician and published in the New England Journal of Medicine finds.
read corporate press release 



Many Skin Cancer Patients Still Too Likely to Sunburn

(Johns Hopkins Medicine) July 19, 2016 - A recent study by researchers at Johns Hopkins concludes that a substantial number of people with a history of the most frequent kind of nonmelanoma skin cancers still get sunburned at the same rate as those without previous history, probably because they are not using sun-protective methods the right way or in the right amounts.
read press release 



Abnormal Uterine Bleeding Can Signal Hematologic Cancer

(Physician’s Briefing/HealthDay News) July 19, 2016 - Among women presenting with a chief complaint of abnormal uterine bleeding (AUB), there is an estimated incidence of hematologic cancer of 3.6 cases per 1,000 women, according to research published in the August issue of Obstetrics & Gynecology.
read article 



Early Treatment of Smoldering Myeloma: Is It Time?

(Medscape Medical News) July 19, 2016 - Patients diagnosed with smoldering myeloma are usually followed with observation until they start to develop symptoms, but now long-term results have confirmed that early treatment can delay progression.
read article (free registration required) 



MRI Is 'Feasible' Prostate Cancer Screening Test

(Medscape Medical News) July 19, 2016 - Last year, the Sunnybrook Health Sciences Centre ran a 1-week ad in the print edition of the biggest local newspaper, the Toronto Star, seeking volunteers for the first study of MRI as a prostate cancer screening tool.
read article (free registration required) 



No One Will Talk About Anal Cancer

(Newsweek) July 20, 2016 - Paulette Crowther said she had colon cancer, but she didn’t. As she fought for her life, only her children and closest family friends knew her real diagnosis: Stage IV anal cancer.
read article 



Cancer Experts Endorse CDC's HPV Vaccine Guidelines

(U.S. News & World Report/HealthDay News) July 19, 2016 - The American Cancer Society has endorsed the U.S. government's HPV vaccination recommendations, which include immunizing all preteens against the sexually transmitted human papilloma virus.
read article 



Study Shows Durable Benefits Of Early HIV Treatment

(Reuters Health) July 18, 2016 - Early treatment of the human immunodeficiency virus (HIV) can dramatically reduce the odds of passing the deadly disease on to others, and the protection persists for years, according to final results from a major study that looked at the timing of antiretroviral therapy, or ART.
read article 



Companies Try New Ways to Attract Patients to Drug Trials

(Wall Street Journal) July 18, 2016 - Pharmaceutical makers monitor online forums to develop effective recruitment approaches and send cars to pick up patient volunteers.
read article (paid subscription required) 



Valeant Stock Higher Ahead of Anticipated FDA Approval

(The Street) July 18, 2016 - Valeant stock is rising this afternoon ahead of tomorrow's PDUFA date for the new drug application of Relistor oral.
read article 



Novartis, World's Top Drugmaker, Plays Down Brexit Threat

(Reuters) July 19, 2016 - Switzerland's Novartis, the world's biggest maker of prescription drugs, will continue to invest in Britain, despite the country's decision to leave the European Union, its chief executive said on Tuesday.
read article 



To Split Or Not To Split? One Wall Street Wag Thinks Pfizer May Remain Intact

(STAT/Pharmalot) July 18, 2016 - After its deal to acquire Allergan fell apart three months ago, Pfizer executives indicated they may split the company into different parts.
read article